Cigna Corp (CI)
Return on equity (ROE)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 5,164,000 | 6,668,000 | 5,365,000 | 8,458,000 | 5,104,000 |
Total stockholders’ equity | US$ in thousands | 46,223,000 | 44,675,000 | 47,112,000 | 50,321,000 | 45,338,000 |
ROE | 11.17% | 14.93% | 11.39% | 16.81% | 11.26% |
December 31, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $5,164,000K ÷ $46,223,000K
= 11.17%
The return on equity (ROE) of Cigna Group (The) has experienced fluctuations over the past five years, ranging from 11.17% in 2023 to 16.81% in 2020. The downward trend from 2020 to 2023 suggests a decreasing ability to generate earnings from shareholders' equity.
The lower ROE in 2023 could indicate reduced profitability or less effective utilization of shareholders' equity compared to previous years. It is important for the company to closely examine the factors contributing to this decline and take necessary actions to improve its profitability and efficiency in utilizing equity.
Overall, the ROE trend for Cigna Group (The) indicates some variability in its performance and highlights the importance of monitoring and addressing the factors influencing its return on equity.
Peer comparison
Dec 31, 2023